• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

Everything we know about the Johnson & Johnson COVID vaccine pause (so far)

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
April 13, 2021, 12:58 PM ET

Tuesday’s surprise recommendation that health care providers pause the use of Johnson & Johnson’s COVID-19 vaccine left a lot of people scrambling. While the one-and-done shot has not been as widespread, in terms of distribution, as those by Moderna and Pfizer, nearly 7 million people already have received it.

The Food and Drug Administration and Centers for Disease Control and Prevention, which issued the guidance, are just beginning their investigations into the reports of potentially dangerous blood clots that occurred in six women in the days after vaccination. Both say the action was taken “out of an abundance of caution,” but that doesn’t answer a lot of questions. Here’s what the agencies have to say about some specific concerns.

I got the J&J vaccine a month (or more) ago. Should I be worried?

Health officials say the risk is very low to people who had the J&J vaccine more than a month ago. Any issues with clotting likely would have presented by now.

I just got a J&J vaccine shot recently. What should I be on alert for?

Again, the odds of developing the clots are low. But CDC Principal Deputy Director Anne Schuchat is suggesting people look for symptoms including severe headache, abdominal pain, leg pain, and shortness of breath. If you develop these within three weeks of getting your J&J shot, contact your health care provider and seek treatment.

She notes, though, that the flu-like symptoms that occur after receiving the vaccine are not things to worry about.

How long will this pause last?

That’s not known precisely right now, but Janet Woodcock, acting FDA commissioner, says “we expect it to be a matter of days.” The CDC says it’s committing to an expeditious review of the available information and an aggressive outreach to physicians so they’ll know how to diagnose, treat, and report issues.

Does this mean I can’t get the J&J COVID vaccine at all now?

No, but it’s probably better to wait. The recommendation is not a mandate, says Dr. Peter Marks, director of the FDA’s center for biologics evaluation and research. “If an individual health care provider has talked with a patient and they determine that the benefit/risk for that patient is appropriate, we’re not going to stop that provider from administering the vaccine.”

That said, expect most mass vaccination sites and pharmacies to follow the advice of the FDA and CDC for now.

I was supposed to get vaccinated this week. What do I do now?

If you have an appointment this week to get the J&J shot, check with your health care provider. Some are already shifting people over to Pfizer or Moderna. Others will reschedule you for another day in the near future, when a Pfizer or Moderna shot is available.

Important: If you have an J&J appt at a NY State-run vax site today (e.g. Javits, Aqueduct), you should still go and you will be offered Pfizer instead.

— Mark D. Levine (@MarkLevineNYC) April 13, 2021

“This may be a bit bumpy,” Schuchat says. “But we do want to make sure people who are scheduled to get vaccinations will be able to get [one] when vaccines are available.”

Are the clots associated with the J&J vaccine fatal?

Of the six cases that have been reported so far, one was fatal and one patient is in critical condition, officials say.

Should I be worried about blood clots with the Moderna or Pfizer vaccine?

The FDA and CDC say there have been no reports of any clotting issues with the other two vaccines being distributed in the U.S. right now. And, to date, there have been over 180 million injections of those, which should allay fears of a similar reaction.

Why did the pause of J&J’s vaccine seemingly come with no warning?

Even the FDA admits this was a sudden action. It comes down to transparency and wanting to prevent possible additional cases.

“I wish we had more time to get everyone prepared and this could have gone even more smoothly,” Woodcock says. “As we learned about the issue…it was clear to us that we needed to alert the public…The decision was based on events that might occur between when we made that realization and when we got the word out.”

What about the European rollout of J&J’s vaccine?

Johnson & Johnson announced Tuesday that it would be proactively delaying the rollout of the vaccine in Europe and would review the cases with European health authorities.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Fortune, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Legion Whey+ Protein Powder Review (2026): Nutrition Expert Approved
HealthDietary Supplements
Legion Whey+ Protein Powder Review (2026): Nutrition Expert Approved
By Christina SnyderApril 9, 2026
20 hours ago
assis
CommentaryIBM
The digital sovereignty dilemma is a false choice — here’s how enterprises can have both
By Ana Paula AssisApril 9, 2026
1 day ago
Best Maca Root Supplements of 2026: Tester and Nutrition Expert Approved
HealthDietary Supplements
Best Maca Root Supplements of 2026: Tester and Nutrition Expert Approved
By Emily PharesApril 7, 2026
3 days ago
Photo of Marc Randolph
Successlifestyle
Netflix cofounder says he stopped work at 5 p.m. every Tuesday for 30 years to stay ‘sane,’ no matter the crisis: ‘Nothing got in the way of that’
By Emma BurleighApril 5, 2026
5 days ago
Peeps in yellow dye on a conveyor belt
HealthFood and drink
‘No one is saying, ‘I want more cancer with my candy”: Why Peeps are a ‘food chemical success story’ despite RFK Jr.’s campaign to destroy their dyes
By Catherina GioinoApril 5, 2026
5 days ago
6 Best Vitamins to Boost Energy (2026): Top Recommendations From Experts
HealthDietary Supplements
6 Best Vitamins to Boost Energy (2026): Top Recommendations From Experts
By Emily PharesApril 3, 2026
7 days ago

Most Popular

The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combined
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combined
By Fortune EditorsApril 9, 2026
23 hours ago
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250
By Fortune EditorsApril 9, 2026
1 day ago
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforce
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforce
By Fortune EditorsApril 9, 2026
1 day ago
White-collar workers are quietly rebelling against AI as 80% outright refuse adoption mandates
AI
White-collar workers are quietly rebelling against AI as 80% outright refuse adoption mandates
By Fortune EditorsApril 9, 2026
1 day ago
Gen Z workers are so fearful AI will take their job they’re intentionally sabotaging their company’s AI rollout
AI
Gen Z workers are so fearful AI will take their job they’re intentionally sabotaging their company’s AI rollout
By Fortune EditorsApril 8, 2026
2 days ago
Current price of oil as of April 9, 2026
Personal Finance
Current price of oil as of April 9, 2026
By Fortune EditorsApril 9, 2026
22 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.